Latest Regulatory News

Neurotech International has secured ethics approval to launch its Beyond Harmony Phase 3 clinical trial of NTI164 for autism spectrum disorder, marking a key step toward regulatory submissions in Australia and the US.

The ASX has suspended trading in Aspermont Limited, Koba Resources, and WA Kaolin due to their failure to lodge required periodic reports on time. The suspension may be lifted if the companies submit their reports promptly.

CurveBeam AI has received the first A$4 million tranche of a planned A$10 million strategic investment from a leading Chinese orthopaedic device company, marking a significant step in its expansion into the Chinese market.

Pivotal Metals has revealed ore sorting test results at its Horden Lake project that deliver up to a 2.1 times uplift in copper grade, promising substantial cost savings and flexible development options in Quebec’s Tier 1 mining jurisdiction.

Imagion Biosystems has submitted its Investigational New Drug application to the U.S. FDA for its MagSense® HER2 Imaging Agent, marking a pivotal step toward launching a Phase 2 clinical trial for breast cancer detection.

Argenica Therapeutics has won a crucial regulatory waiver from the European Medicines Agency, removing the need for paediatric trials for its stroke drug ARG-007 and clearing the way for faster adult market approval in Europe.

Recce Pharmaceuticals has secured a second Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research to test its RECCE 327 Gel in burn wound infection models, underscoring growing military interest in its synthetic anti-infectives.

Arika Resources has agreed to acquire the remaining 20% stake in its flagship Yundamindra and Kookynie gold projects, consolidating full ownership and positioning itself for accelerated exploration in Western Australia’s prolific goldfields.

Taiton Resources has completed a significant placement of nearly 12 million shares to Singapore’s GEMS Strategic Resource Fund, bolstering its capital position and signalling confidence from a reputable international investor.

Hawsons Iron Limited has secured $2.2 million through a discounted share placement, accompanied by free attaching options, to advance key studies and optimisations for its iron project in New South Wales.

Rincon Resources has secured drilling approvals for its Hasties gold-copper deposits near Telfer, aiming to expand mineralisation and update its resource estimate by the end of Q1 2026.

Memphasys Limited secures significant repeat orders from Hamad Medical Corporation, marking a pivotal expansion of its Felix™ system across the MENA region.